EMSP Annual Report 2024

15.05.2025

The European Multiple Sclerosis Platform presents our 2024 Annual Report, documenting a year of significant achievements in our mission to improve the quality of life for people affected by Multiple Sclerosis (MS), Neuromyelitis Optica Spectrum Disorders (NMOSD) and Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease (MOGAD) throughout Europe.

As we reflect on the past year, we are proud of the collaborative efforts that have strengthened our community and advanced our strategic priorities. Through advocacy, research partnerships, and member engagement, we have continued to amplify the voice of people with MS and related disorders at European level.

This report outlines our key achievements, financial performance, and the impact of our initiatives. It also a reflection of the invaluable contributions of our member organisations, partners, and supporters who make our work possible.

As we look ahead, we remain committed to driving meaningful change in care, treatment access, and support services for MS and related disorders.

DOWNLOAD

Our Recommendations